US Stock MarketDetailed Quotes
PBM Psyence Biomedical
- 1.100
- +0.040+3.77%
Close May 9 16:00 ET
- 1.130
- +0.030+2.73%
Pre 05:20 ET
14.73MMarket Cap-218P/E (TTM)
1.150High1.040Low108.48KVolume1.060Open1.060Pre Close119.33KTurnover1.01%Turnover RatioLossP/E (Static)13.39MShares14.55052wk High-3.77P/B11.87MFloat Cap0.51452wk Low--Dividend TTM10.79MShs Float14.550Historical High--Div YieldTTM10.38%Amplitude0.514Historical Low1.100Avg Price1Lot Size
About Psyence Biomedical Company
Psyence Biomedical Ltd. is a life science biotechnology company. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company was founded on June 29, 2023 and is headquartered in Toronto, Canada.
Company Profile
SymbolPBM
Company NamePsyence Biomedical
Listing DateDec 10, 2021
Founded2023
CEODr. Neil Maresky
MarketNASDAQ
Securities TypeOrdinary Shares
Fiscal Year Ends03-31
Address121 Richmond Street West,Penthouse Suite 1300
CityToronto
ProvinceOntario
CountryCanada
Zip CodeM5H 2K1
Phone1-416-346-7764
Websitehttp://psyence.com
Company Executives
- Name
- Position
- Salary
- Dr. Neil Maresky
- Chief Executive Officer and Director
- 422.45K
- Jody Aufrichtig
- Chairman of the Board and Strategic Business Development Officer
- 278.83K
- Marc Gregory Balkin
- Independent Director
- --
- Christopher Bull
- Independent Director
- --
- Dr. Seth Feuerstein
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg